Biotech Stocks
The latest news, updates and opinions on Biotech Stocks from the expert team here at MoneyWeek
Latest
-
How to profit from the development of new auto-immune disease drugs
Tips Some debilitating conditions are caused by the body’s defence mechanism going awry. Dr Mike Tubbs appraises a key subsector of the pharmaceuticals market.
By Dr Mike Tubbs Published
Tips -
Cash injection: join the hunt for a coronavirus vaccine
Tips Covid-19 has renewed interest in preventing the spread of viruses. But the appeal of this rapidly growing sub-sector of the pharmaceuticals market should endure far beyond the pandemic. Matthew Partridge explains.
By Dr Matthew Partridge Last updated
Tips -
The MoneyWeek Podcast: the accelerating revolution in healthcare
Podcasts Merryn talks to Dr Paul Jordan, Anna Macdonald, and Dr Gareth Blades of Amati Global investors about some of their favourite small UK companies - including the opportunities in healthcare and biotech stocks, and how the sector has responded to the pandemic.
By moneyweek Published
Podcasts -
The race for a coronavirus vaccine heats up
News Biotech shares, led by AstraZeneca, are lifted in the race to come up with a coronavirus vaccine.
By Dr Matthew Partridge Published
News -
Which Covid-19 vaccines look likely to be the best bets?
News The race to produce a treatment to prevent Covid-19 has hundreds of entrants. How should investors approach it? Matthew Partridge reports.
By Dr Matthew Partridge Published
News -
The race to defeat the superbugs has just begun
Analysis Drug-resistant bacteria are far more dangerous than Covid-19. So will we soon see major progress in developing new antibiotics? It will be a long slog, says Ben Judge.
By Ben Judge Published
Analysis -
Gilead's takeover of Forty Seven should soothe shareholders' worries
News Gilean, the biopharma giant, is stocking up on potentially lucrative cancer drugs by snapping up smaller operators.
By Dr Matthew Partridge Published
News -
The drugs don’t work: stopping the spread of the superbugs
Cover Story Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical companies are fighting back. Sarah Moore reports.
By Sarah Moore Published
Cover Story -
If you'd invested in: GW Pharmaceuticals and Trinity Mirror
Features GW Pharmaceuticals makes medicine from cannabis, while Trinity Mirror is the country’s biggest newspaper, magazine and digital publisher.
By Ben Judge Published
Features